Asked by: Tracey Crouch (Conservative - Chatham and Aylesford)
Question to the Home Office:
To ask the Secretary of State for the Home Department, how many 16 to 25 year olds have been arrested for rough sleeping under the Vagrancy Act.
Answered by Chris Philp - Minister of State (Home Office)
The government does not collect figures on police usage of the Vagrancy Act where this does not result in prosecution. Policing is operationally independent of the Home Office, and we cannot comment on operational decisions.
Asked by: Caroline Lucas (Green Party - Brighton, Pavilion)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, what steps he is taking to reduce levels of incineration of plastic.
Answered by Robbie Moore - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
We are clear that we want to see less residual waste being generated in the first instance. To this end, in addition to our Collection and Packaging Reforms, we have set a statutory target under The Environmental Targets (Residual Waste) (England) Regulations 2023 to ensure that the total mass of residual waste (excluding major mineral wastes) for 2042 does not exceed 287 kg per person. This is the equivalent of a 50% reduction from 2019 levels. This is supported by an interim, non-statutory target set out in the Environmental Improvement Plan to ensure that residual municipal plastic waste for 2027 does not exceed 42 kg per person.
We are also working closely with DESNZ on the expansion of the UK Emissions Trading Scheme to cover fossil carbon emissions from waste incineration and EfW from 2028. This will provide an incentive for the development and uptake of decarbonisation technologies or waste management practices to reduce emissions from incineration of residual waste plastic.
Asked by: Navendu Mishra (Labour - Stockport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent steps she has taken to help reduce waiting times for child and adolescent mental health services in Stockport constituency.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
We want to ensure that children and young people get the mental health support they need, including in the Stockport constituency, and overall spending on mental health has increased by more than £4.7 billion in cash terms since 2018/19. This has enabled an expansion of child and young people's mental health services. As of January 2024, the latest data from NHS Digital shows there were 758,485 children and young people aged under 18 years old, supported through National Health Service funded mental health services with at least one contact.
We have introduced two waiting-time standards for children and young people. The first is for 95% of children, up to 19 years old, with eating disorders to receive treatment within one week for urgent cases, and four weeks for routine cases. The second is for 50% of patients of all ages experiencing a first episode of psychosis to receive treatment within two weeks of referral.
NHS England is developing a new waiting time measure for children and their families and carers to start to receive community-based mental health care within four weeks from referral. NHS England began publishing this new data in 2023 to improve transparency and drive local accountability.
Asked by: Caroline Lucas (Green Party - Brighton, Pavilion)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make a comparative assessment of the adequacy of the reasons the (a) National Institute for Health and Care Excellence has been unable and (b) Scottish Medicines Consortium has been able to recommend Enhertu for use on the NHS.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) makes authoritative, evidence-based recommendations for the National Health Service in England on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits. Decisions on the availability of medicines in Scotland are a matter for the devolved administration.
The NICE published guidance in 2021 and 2023 recommending Enhertu, also known as trastuzumab deruxtecan, for the treatment of NHS patients with HER2-positive breast cancer through the Cancer Drugs Fund, and it is now available to eligible NHS patients in England in line with the NICE’s recommendations.
The NICE is currently evaluating Enhertu for the treatment of metastatic HER2-low breast cancer, and has not yet published final guidance. Stakeholders have had an opportunity to appeal against the NICE’s draft recommendations, and the NICE will consider any appeals through the established process and publish final guidance in due course.
Asked by: John Hayes (Conservative - South Holland and The Deepings)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether NICE is taking steps to make Enhertu available to the National Health Service to treat incurable HER2-low secondary breast cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) is currently developing guidance for the National Health Service on whether Enhertu can be recommended for routine NHS funding, based on an assessment of the costs and benefits. The NICE was unfortunately unable to recommend Enhertu as a clinically and cost-effective use of NHS resources in its final draft guidance published on 5 March 2024. Stakeholders have had an opportunity to appeal against the NICE’s draft recommendations, and the NICE will consider any appeals through the established process, and will publish final guidance in due course.
Asked by: Lord Arbuthnot of Edrom (Conservative - Life peer)
Question to the Foreign, Commonwealth & Development Office:
To ask His Majesty's Government what assessment they have made of the World Food Programme's ability to scale up its humanitarian operation in Gaza.
Answered by Lord Ahmad of Wimbledon - Minister of State (Foreign, Commonwealth and Development Office)
We continue to support the United Nations World Food Programme (WFP).
On 20 March, the Foreign Secretary announced that the UK has funded WFP to provide 2,000 tons of food aid, enough to feed 275,000 people in Gaza. This is our largest delivery of aid to Gaza during the current crisis.
We remain committed to getting humanitarian aid to the people in Gaza who desperately need it, including through UN agencies and British charities.
Asked by: Jane Hunt (Conservative - Loughborough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make it her policy to allow pharmacies to sell vitamin B12 injections.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
To make a medicinal product available for sale in a pharmacy without a prescription, the product must be reclassified to pharmacy only status, also known as [P] medicines, by the Medicines and Healthcare products Regulatory Agency (MHRA).
This process is triggered by an application submitted to the MHRA by a company which holds a licence for the particular product. The MHRA will consider all submitted applications, with a decision to reclassify a medicine reached following a robust evaluation of the relevant data, including evidence of the safe use and supply of the product without a prescription. The company must also demonstrate in their application that the criteria specified in relevant legislation, such as the Human Medicines Regulations 2012, have been met.
In accordance with the Human Medicines Regulations 2012, regulation 62(3), Prescription-Only Medicine status will apply where: a direct or indirect danger exists to human health, even when used correctly, if used without medical supervision; there is frequently incorrect use, which could lead to direct or indirect danger to human health; further investigation of the activity or side-effects is required; or the product is normally prescribed for parenteral administration, via injection.
Currently, United Kingdom law specifies that all products administered by injection must be subject to a prescription. The MHRA is therefore unable to reclassify the status of injections, including Vitamin B12, to [P] medicines, as this would not be consistent with the legislation.
Asked by: Gen Kitchen (Labour - Wellingborough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support the recruitment and retention of mental health specialists in Wellingborough constituency.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To deliver the NHS Long Term Plan’s mental health commitments and help reduce waiting times in the Wellingborough constituency and nationwide, our aim has been to grow the mental health workforce nationally by an additional 27,000 professionals by March 2024.
We are making positive progress, delivering three quarters of this, or approximately 20,800 new professionals, by December 2023, with further growth expected to have been achieved once the full year figures for 2023/24 are available. This growth is in addition to the commitment to grow the National Health Service’s mental health workforce by 19,000 between 2016/17 and 2020/21, as set out in Stepping Forward to 2020/21: the mental health workforce plan for England, which was achieved in September 2021.
At a national level, we are committed to attracting, training, and recruiting the mental health workforce of the future, as well as retaining and developing our current workforce. The NHS Long Term Workforce Plan’s modelling projections set out a need to grow the overall mental health and learning disability workforce the fastest of all care settings, at 4.4% per year up to 2036/37, to help improve access to services and quality of care.
Asked by: Nick Smith (Labour - Blaenau Gwent)
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, with reference to the oral contribution of the Minister for Defence Procurement in response to the question from the hon. Member for Blaenau Gwent on 25 March 2024, Official Report, column 1253, how many RAF pilots successfully completed their training in each year since 2018.
Answered by Leo Docherty - Minister of State (Ministry of Defence) (Minister for the Armed Forces)
Training Year (April to March) | Number of Royal Air Force (RAF) pilots successfully completed Phase 2 Military Flying Training |
2018-19 | 34 |
2019-20 | 67 |
2020-21 | 72 |
2021-22 | 73 |
2022-23 | 64 |
2023-24 | 51 |
Note: The figures detailed in the table above are for RAF pilots who successfully completed Phase 2 military flying training. Phase 2 flying training is defined as commencing after completion of Initial Officer Training (IOT) and up until (but not including) Front Line Operational Conversion Units (OCUs).
Asked by: Nadia Whittome (Labour - Nottingham East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of variations in access to appropriate social care provision to enable independent living on the (a) availability and (b) capacity of supported accommodation.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Our white paper People at the Heart of Care sets out our ambition to ensure people have the choice and control to remain independent in the community. We recognise that supported housing can be the best model of care for some people, leading to better health, greater independence, and closer connection with the community.
The forthcoming provisions of the Supported Housing (Regulatory Oversight) Act 2023 will strengthen the data on the availability and capacity of supported accommodation. The act places a new duty on local housing authorities to review the supported housing in each district, and to forecast future need. The Government will consult on the implementation of the new duties and other supported housing reforms in due course.